Breast Cancer Res. 2009;11(1):202. Epub 2009 Feb 26.

Transforming growth factor-beta in breast cancer: too much, too late.

Source

New York University Langone School of Medicine, New York, NY 10016, USA. mhbarcellos-hoff@nyumc.org

Abstract

The contribution of transforming growth factor (TGF)beta to breast cancer has been studied from a myriad perspectives since seminal studies more than two decades ago. Although the action of TGFbeta as a canonical tumor suppressor in breast is without a doubt, there is compelling evidence that TGFbeta is frequently subverted in a malignant plexus that drives breast cancer. New knowledge that TGFbeta regulates the DNA damage response, which underlies cancer therapy, reveals another facet of TGFbeta biology that impedes cancer control. Too much TGFbeta, too late in cancer progression is the fundamental motivation for pharmaceutical inhibition.

PMID:: 19291273; [PubMed - indexed for MEDLINE]
PMCID: PMC2687712

Free PMC Article

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Transforming Growth Factor beta

Grant Support

R01 CA 116019/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Cancer - MedlinePlus Health Information

Libraries

LinkOut Holdings

Supplemental Content

Related citations

Review Targeting TGFbeta signaling for cancer therapy. [Cancer Biol Ther. 2005]
Review Targeting TGFbeta signaling for cancer therapy.
Iyer S, Wang ZG, Akhtari M, Zhao W, Seth P. Cancer Biol Ther. 2005 Mar; 4(3):261-6. Epub 2005 Mar 28.
Review TGF beta inhibition for cancer therapy. [Curr Cancer Drug Targets. 2006]
Review TGF beta inhibition for cancer therapy.
Saunier EF, Akhurst RJ. Curr Cancer Drug Targets. 2006 Nov; 6(7):565-78.
Review TGFbeta in Cancer. [Cell. 2008]
Review TGFbeta in Cancer.
Massagué J. Cell. 2008 Jul 25; 134(2):215-30.
Review Dual role of transforming growth factor beta in mammary tumorigenesis and metastatic progression. [Clin Cancer Res. 2005]
Review Dual role of transforming growth factor beta in mammary tumorigenesis and metastatic progression.
Muraoka-Cook RS, Dumont N, Arteaga CL. Clin Cancer Res. 2005 Jan 15; 11(2 Pt 2):937s-43s.
Review Roles of TGFbeta in metastasis. [Cell Res. 2009]
Review Roles of TGFbeta in metastasis.
Padua D, Massagué J. Cell Res. 2009 Jan; 19(1):89-102.

See reviews... See all...

Cited by 12 PubMed Central articles

Review TGF-β signaling in breast cancer cell invasion and bone metastasis. [J Mammary Gland Biol Neoplasia. 2011]
Review TGF-β signaling in breast cancer cell invasion and bone metastasis.
Drabsch Y, ten Dijke P. J Mammary Gland Biol Neoplasia. 2011 Jun; 16(2):97-108. Epub 2011 Apr 15.
C/EBPδ: friend or foe? a novel role for C/EBPδ in metastasis. [EMBO J. 2010]
C/EBPδ: friend or foe? a novel role for C/EBPδ in metastasis.
Pelorosso FG, Balmain A. EMBO J. 2010 Dec 15; 29(24):4063-5.
Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers. [Breast Cancer Res. 2010]
Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers.
Walker LC, Fredericksen ZS, Wang X, Tarrell R, Pankratz VS, Lindor NM, Beesley J, Healey S, Chen X, kConFab, et al. Breast Cancer Res. 2010; 12(6):R102. Epub 2010 Nov 29.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Transforming growth factor-beta in breast cancer: too much, too late.
Transforming growth factor-beta in breast cancer: too much, too late.
Breast Cancer Res. 2009 ;11(1):202. Epub 2009 Feb 26 .

PubMed
Notch versus the proteasome: what is the target of gamma-secretase inhibitor-I?
Notch versus the proteasome: what is the target of gamma-secretase inhibitor-I?
Breast Cancer Res. 2009 ;11(5):110.

PubMed
Prevalence of Khat chewing in college and secondary (high) school students of Ja...
Prevalence of Khat chewing in college and secondary (high) school students of Jazan region, Saudi Arabia.
Harm Reduct J. 2009 Jun 20 ;6:11.

PubMed
Recent advances in systemic therapy: Advances in systemic therapy for HER2-posit...
Recent advances in systemic therapy: Advances in systemic therapy for HER2-positive metastatic breast cancer.
Breast Cancer Res. 2009 ;11(4):207. Epub 2009 Jul 15 .

PubMed
Controlling cell division in yeast and animals: does size matter?
Controlling cell division in yeast and animals: does size matter?
J Biol. 2003 ;2(1):5. Epub 2003 Apr 24 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: